ESSA Pharma to Hold Annual Shareholders' Meeting and Announces Three Realm-Nominated Directors

HOUSTON, TX and VANCOUVER, June 21, 2019 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (Nasdaq: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer reminds investors that ESSA will hold its Annual General...

from PR Newswire: https://prn.to/2Ix3kjO